Wallichin D

ID: ALA5171650

Chembl Id: CHEMBL5171650

PubChem CID: 168270051

Max Phase: Preclinical

Molecular Formula: C42H56O10

Molecular Weight: 720.90

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CC[C@H]2[C@@](C)(CCC[C@]2(C)C(=O)O)[C@@H]1C/C=C(\C)[C@H]1CCc2c(O)c(CC3C(=O)C(C(C)=O)=C(O)C(C)(C)C3O)c(O)c(C(=O)CCC)c2O1

Standard InChI:  InChI=1S/C42H56O10/c1-9-11-28(44)32-34(46)25(20-26-35(47)31(23(4)43)38(49)40(5,6)37(26)48)33(45)24-14-16-29(52-36(24)32)22(3)12-15-27-21(2)13-17-30-41(27,7)18-10-19-42(30,8)39(50)51/h12,26-27,29-30,37,45-46,48-49H,2,9-11,13-20H2,1,3-8H3,(H,50,51)/b22-12+/t26?,27-,29-,30+,37?,41+,42+/m1/s1

Standard InChI Key:  PUHUUEYLYYLTGI-ZNALYMAFSA-N

Alternative Forms

  1. Parent:

    ALA5171650

    ---

Associated Targets(Human)

Calu-3 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TMPRSS2 Tchem Transmembrane protease serine 2 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE2 Tchem Angiotensin-converting enzyme 2 (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero C1008 (1716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
S Spike glycoprotein (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
N Nucleoprotein (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 720.90Molecular Weight (Monoisotopic): 720.3873AlogP: 7.50#Rotatable Bonds: 10
Polar Surface Area: 178.66Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.47CX Basic pKa: CX LogP: 7.92CX LogD: 1.79
Aromatic Rings: 1Heavy Atoms: 52QED Weighted: 0.09Np Likeness Score: 2.22

References

1. Hou B, Zhang YM, Liao HY, Fu LF, Li DD, Zhao X, Qi JX, Yang W, Xiao GF, Yang L, Zuo ZY, Wang L, Zhang XL, Bai F, Yang L, Gao GF, Song H, Hu JM, Shang WJ, Zhou J..  (2022)  Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2.,  85  (2.0): [PMID:35084181] [10.1021/acs.jnatprod.1c00805]

Source